This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1995;50(4):533-51.

J Strobos. Food Drug Law J. 1995.

. 1995;50(4):533-51.

No abstract available

What drug labels don't tell you.
[No authors listed] [No authors listed] Consum Rep. 2011 Aug;76(8):10. Consum Rep. 2011. PMID: 21770080 No abstract available.
Regulation of pharmacoeconomics and outcomes research.
Radensky P. Radensky P. Value Health. 2001 Jan-Feb;4(1):12-5. doi: 10.1046/j.1524-4733.2001.004001012.x. Value Health. 2001. PMID: 11704968 No abstract available.
Regulating manufacturer-affiliated communication in the information age.
Schulman KA, Abernethy DR, Rathore SS, Woosley RL. Schulman KA, et al. Clin Pharmacol Ther. 1999 Jun;65(6):593-7. doi: 10.1016/S0009-9236(99)90080-2. Clin Pharmacol Ther. 1999. PMID: 10391664 No abstract available.
Direct-to-consumer prescription drug advertising.
Terzian TV. Terzian TV. Am J Law Med. 1999;25(1):149-67. Am J Law Med. 1999. PMID: 10207573 Review. No abstract available.
Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.
Kopp SW, Bang HK. Kopp SW, et al. Health Mark Q. 2000;17(3):39-56. doi: 10.1300/J026v17n03_04. Health Mark Q. 2000. PMID: 11010219 Review.